| Literature DB >> 35882820 |
Michelle A Vasquez1,2, George B Cruz2,3, Ericka Cabañas2,3, Jewel N Joseph2,3, Mohammad Mian2,3, Sai Karthik V Madhira2,3, Chelsea A Akintunde2,3, Evan G Clarke2,3, Jourvonn C Skeen2,3, Jalen R Bonitto2,3, Eric B Khairi2,3, Kirsten P Lynch2,4, Narmin H Mekawy5,6, Abdeslem El Idrissi5,6, Youngjoo Kim1, Bright U Emenike1, Lorenz S Neuwirth7,8.
Abstract
Lead (Pb2+) is a developmental neurotoxicant that disrupts the GABA-shift and subsequently causes alterations in the brain's excitation-to-inhibition (E/I) balance. This finding suggests that neurodevelopmental Pb2+ exposures may increase the risk of brain excitability and/or seizure susceptibility. Prior studies have suggested that neurodevelopmental Pb2+ exposures may cause excitotoxicity of cholinergic neurons, but little to no research has further investigated these potential relationships. The present study sought to evaluate the potential for perinatal neurodevelopmental Pb2+ exposures of 150 ppm and 1000 ppm on pilocarpine-induced seizures through the M1 receptor. The study also evaluated the potential for sex- and treatment-dependent differences in brain excitability. The study revealed that Control females have elevated cholinergic brain excitability and decreased GABAergic inhibition in response to pilocarpine-induced seizures. At low Pb2+ exposures, males exhibited more cholinergic brain excitability, whereas at higher Pb2+ exposures, females exhibited more cholinergic brain excitability. Further, taurine was able to provide neuroprotection against pilocarpine-induced seizures in males, whereas females did not reveal such observations. Thus, the present study adds new insights into the potential for cholinergic seizure susceptibility as a function of sex and the dosage ofneurodevelopmental Pb2+ exposure and how taurine may provide selective pharmacodynamics to treat or recover cholinergic system aberrations induced by neurotoxicants.Entities:
Keywords: Anxiety-like behaviors; Anxiolytic drugs; Developmental lead exposure; GABAergic system; Lead poisoning; Taurine derivatives
Mesh:
Substances:
Year: 2022 PMID: 35882820 DOI: 10.1007/978-3-030-93337-1_44
Source DB: PubMed Journal: Adv Exp Med Biol ISSN: 0065-2598 Impact factor: 3.650